lucentis 1.65mg0.165ml solution for injection pre-filled syringes
novartis pharmaceuticals uk ltd - ranibizumab - solution for injection - 10mg/1ml
lucentis 10 mg/ml solution for injection in pre-filled syringe
novartis corporation (malaysia) sdn. bhd. - ranibizumab -
cable/lead, electrocardiograph, radiolucent
global medical solutions australia pty limited - 36038 - cable/lead, electrocardiograph, radiolucent - radiolucent leadwires are intended for use in x-ray imaging environments, to connect electrodes placed at appropriate sites on the patient to an ecg/ekg device for general monitoring and/or diagnostic evaluation by a healthcare professional. be sure to read and follow all the instructions that come with the ivy biomedical monitor.
lucentis solution for injection in pre-filled syringe 1.65mg0.165ml
novartis (singapore) pte ltd - ranibizumab - injection, solution - ranibizumab 1.65mg/0.165ml
lucentis solution
novartis pharmaceuticals canada inc - ranibizumab - solution - 10mg - ranibizumab 10mg - eent drugs, miscellaneous
lucentis solution
novartis pharmaceuticals canada inc - ranibizumab - solution - 10mg - ranibizumab 10mg - eent drugs, miscellaneous
lucentis 10 mg/ml
شركة مستودع الأدوية الأردني - the jordan drugstore co - ranibizumab 10 mg/ml - 10 mg/ml
imlygic talimogene laherparepvec one hundred million pfu/ml injection solution vial
amgen australia pty ltd - talimogene laherparepvec -
imlygic talimogene laherparepvec one million pfu/ml injection solution vial
amgen australia pty ltd - talimogene laherparepvec -
cable/lead, electrocardiograph, radiolucent
cardinal health australia 503 pty ltd - 36038 - cable/lead, electrocardiograph, radiolucent - the device is intended for transmitting the impulses detected by the electrodes to the recorders of electrocardiograph monitors. the leads are fabricated with radiolucent material.